PTPN1 and type 2 diabetes mellitus: The expression of PTP1B can be augmented by alterations in protein tyrosine kinases (PTKs) activity [62], which leads to impaired binding of insulin receptors to target tissues such as those observed in T2D, obesity, insulin resistance, and leptin deficiency [63].